Crizotinib/Xalkori price analysis in 2025: How much does a box cost? Interpretation of medical insurance policies

Crizotinib is a targeted therapy drug mainly used to treat non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) gene rearrangement. It inhibits the activity of targets such as ALK to prevent the proliferation and spread of cancer cells, thereby effectively delaying disease progression. The introduction of crizotinib has provided a new treatment option for these specific patients, significantly improving their prognosis.

In China, crizotinib is marketed in the form of capsules, mainly in two dosage sizes: 250mg and 200mg, with each box containing 60 capsules. Depending on market conditions, the price of this drug is usually more than 10,000 yuan. Of course, specific prices will vary by region, hospital, pharmacy and supply chain. In addition, after entering the medical insurance catalog, the actual burden of drugs may be reduced, but the medical insurance policies and reimbursement ratios of each province and city are different, so the specific cost needs to be understood by patients according to the policies of their own region.

Regarding medical insurance policy, crizotinib, as a targeted drug, was included in the drug catalog of the National Medical Insurance Administration in 2017 and is supported by medical insurance. This means that eligible patients can enjoy a certain percentage of cost reimbursement when purchasing the drug in the hospital, reducing the patient's financial burden.

However, the specific reimbursement ratio and conditions will vary from region to region, and some places may require patients to undergo relevant genetic testing before using the drug to confirm its suitability so that they can enjoy medical insurance benefits. Therefore, patients should consult the medical insurance department of their hospital for detailed information before use to ensure that their medication is covered accordingly.

Reference materials:https://go.drugbank.com/drugs/DB08865